Targeting ROS in cancer: rationale and strategies
- PMID: 38982305
- DOI: 10.1038/s41573-024-00979-4
Targeting ROS in cancer: rationale and strategies
Abstract
Reactive oxygen species (ROS) in biological systems are transient but essential molecules that are generated and eliminated by a complex set of delicately balanced molecular machineries. Disruption of redox homeostasis has been associated with various human diseases, especially cancer, in which increased ROS levels are thought to have a major role in tumour development and progression. As such, modulation of cellular redox status by targeting ROS and their regulatory machineries is considered a promising therapeutic strategy for cancer treatment. Recently, there has been major progress in this field, including the discovery of novel redox signalling pathways that affect the metabolism of tumour cells as well as immune cells in the tumour microenvironment, and the intriguing ROS regulation of biomolecular phase separation. Progress has also been made in exploring redox regulation in cancer stem cells, the role of ROS in determining cell fate and new anticancer agents that target ROS. This Review discusses these research developments and their implications for cancer therapy and drug discovery, as well as emerging concepts, paradoxes and future perspectives.
© 2024. Springer Nature Limited.
Similar articles
-
Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies.Antioxid Redox Signal. 2024 Aug;41(4-6):322-341. doi: 10.1089/ars.2023.0445. Epub 2024 Apr 1. Antioxid Redox Signal. 2024. PMID: 38445392 Review.
-
Reactive oxygen species (ROS) in cancer pathogenesis and therapy: An update on the role of ROS in anticancer action of benzophenanthridine alkaloids.Biomed Pharmacother. 2021 Nov;143:112142. doi: 10.1016/j.biopha.2021.112142. Epub 2021 Sep 15. Biomed Pharmacother. 2021. PMID: 34536761 Review.
-
Modulation of oxidative stress as an anticancer strategy.Nat Rev Drug Discov. 2013 Dec;12(12):931-47. doi: 10.1038/nrd4002. Nat Rev Drug Discov. 2013. PMID: 24287781 Review.
-
Experimental therapeutics: targeting the redox Achilles heel of cancer.Curr Opin Investig Drugs. 2007 Dec;8(12):1022-37. Curr Opin Investig Drugs. 2007. PMID: 18058573 Review.
-
The Regulation of Pathways of Inflammation and Resolution in Immune Cells and Cancer Stem Cells by Selenium.Adv Cancer Res. 2017;136:153-172. doi: 10.1016/bs.acr.2017.07.003. Epub 2017 Aug 31. Adv Cancer Res. 2017. PMID: 29054417 Free PMC article. Review.
Cited by
-
Inconsistencies in predictive models based on exhaled volatile organic compounds for distinguishing between benign pulmonary nodules and lung cancer: a systematic review.BMC Pulm Med. 2024 Nov 2;24(1):551. doi: 10.1186/s12890-024-03374-2. BMC Pulm Med. 2024. PMID: 39488679 Free PMC article.
-
Lanthanum-based dendritic mesoporous nanoplatform for tumor microenvironment activating synergistic anti-glioma efficacy.Mater Today Bio. 2024 Sep 3;28:101223. doi: 10.1016/j.mtbio.2024.101223. eCollection 2024 Oct. Mater Today Bio. 2024. PMID: 39290466 Free PMC article.
-
Elucidating the role of CYFIP2 in conferring cisplatin resistance in esophageal squamous cell carcinoma.Sci Rep. 2024 Nov 7;14(1):27130. doi: 10.1038/s41598-024-77420-8. Sci Rep. 2024. PMID: 39511293 Free PMC article.
-
HKDC1 functions as a glucose sensor and promotes metabolic adaptation and cancer growth via interaction with PHB2.Cell Death Differ. 2024 Dec;31(12):1595-1610. doi: 10.1038/s41418-024-01392-5. Epub 2024 Oct 7. Cell Death Differ. 2024. PMID: 39375512
-
Blood Cell Membrane-Coated Nanomaterials as a Versatile Biomimetic Nanoplatform for Antitumor Applications.Nanomaterials (Basel). 2024 Oct 31;14(21):1757. doi: 10.3390/nano14211757. Nanomaterials (Basel). 2024. PMID: 39513837 Free PMC article. Review.
References
-
- Halliwell, B. Reactive oxygen species (ROS), oxygen radicals and antioxidants: where are we now, where is the field going and where should we go? Biochem. Biophys. Res. Commun. 633, 17–19 (2022). - PubMed
-
- Sies, H. et al. Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology. Nat. Rev. Mol. Cell Biol. 23, 499–515 (2022). - PubMed
-
- Gorrini, C., Harris, I. S. & Mak, T. W. Modulation of oxidative stress as an anticancer strategy. Nat. Rev. Drug Discov. 12, 931–947 (2013). - PubMed
-
- Trachootham, D., Alexandre, J. & Huang, P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discov. 8, 579–591 (2009). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials